2 completed, 1 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Terminated 1 |
Follow vilaprisan: new trials by email Literature Review of vilaprisan trials Research Report on vilaprisan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis Vilaprisan (BAY1002670), Matching Placebo - Endometriosis | Phase 2 | Terminated | Bayer | 8 | 2018-07-04 | 2022-05-04 |
| Assess Safety and Efficacy of Vilaprisan in Patients With Uterine Fibroids Vilaprisan (BAY1002670), Vilaprisan (BAY1002670, Ulipristal - Leiomyoma | Phase 2 | Completed | Bayer | 120 | 2015-06-01 | 2016-11-22 |
| Bay1002670, Fibroids, Safety and Efficacy EU,US,Can, Jap BAY1002670, Placebo - Leiomyoma | Phase 2 | Completed | Bayer | 309 | 2014-05-15 | 2017-12-08 |
Leiomyoma (2) · Endometriosis (1) · Menorrhagia (1)
Bayer (3)
Czechia (3) · Finland (3) · Austria (2) · Belgium (2) · Bulgaria (2) · Canada (2) · Germany (2) · Hungary (2) · Italy (2) · Japan (2) · Norway (2) · Poland (2) · Spain (2) · Sweden (2) · United States (2)
PMID 30527839, PMID 30682081, PMID 32559602, PMID 38983729
2014 (1)